Sentiments Surrounding At-Home Diagnostic Testing
July 18, 2024
In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s general manager of biopharma, discusses findings of a new physician survey that the company conducted.